Understanding the different types of risks faced by people with essential thrombocythemia, a type of cancer associated with uncontrolled growth of blood platelets, is crucial to helping patients live ...

When being diagnosed with a myeloproliferative neoplasm (MPN), it is crucial — though oftentimes difficult — to come to the proper diagnosis, especially when differentiating between two subtypes of ...

The risk of venous and arterial thrombosis in polycythemia vera patients with secondary malignancies. Temporal trends in myeloproliferative neoplasms–related mortality in the United States over the ...

In patients with essential thrombocythemia (ET) who fail to respond to the initial therapy of hydroxyurea, the interferon drug ropeginterferon alfa-2b (ropeg) showed significantly improved responses ...